Optionale Produktanalyse
Mit Ihrer Erlaubnis verwenden wir datenschutzfreundliche Analysen, um zu verstehen, welche Recherchewege funktionieren. Wir verwenden weder Werbe-Tracker noch Sitzungsaufzeichnungen. Sie können diese Auswahl in den Einstellungen ändern. Lesen Sie die Datenschutzerklärung.
Parker-Hannifin Corporation's published Sell conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $120.8B | |
|---|---|---|
| Revenue (ttm) | 21.5B | |
| Net income (ttm) | 3.6B | |
| EPS (ttm) | $28.5 | |
| Shares out | 126.1M | |
| P/E (trailing) | 32.0x | |
| P/E (forward) | 27.5x | |
| Dividend | $8.00 (0.88%) | |
| Volume | 359,606 | |
| Beta | 1.12 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | 2026-06-30 | Trend |
| Revenue | $15.86B | $19.07B | $19.93B | $19.85B | $21.50B | +7.9% |
| Gross profit | $4.39B | $6.46B | $7.16B | $7.32B | $8.10B | +16.6% |
| Operating income | $2.98B | $3.40B | $4.07B | $4.35B | $5.07B | +14.2% |
| Net income | $1.32B | $2.08B | $2.84B | $3.53B | $3.65B | +29.1% |
| EPS (diluted) | $10.09 | $16.04 | $21.84 | $27.12 | $28.48 | +29.6% |
| EBITDA | $2.44B | $4.07B | $5.03B | $5.42B | $5.90B | +24.7% |
| R&D | $191.0M | $258.0M | $253.0M | $240.0M | $267.0M | +8.7% |
| SG&A | $2.50B | $3.35B | $3.32B | $3.26B | $3.47B | +8.5% |
Recent company headlines from major financial publishers.
Commercial aerospace build rates ramp aggressively while aftermarket pricing remains elevated, propelling Aerospace Systems organic growth and driving consolidated operating margins toward peak targets. Synergy realization from Filtration Group and CIRCOR accelerates, driving strong compound earnings growth.
Management executes the Win Strategy to deliver steady revenue growth, with operating margins expanding across the forecast horizon. Free cash flow margin sustains near target levels, funding disciplined debt paydown and steady capital returns.
| Ke ↓ / g → | 2.3% | 2.5% | 2.8% | 3.0% | 3.3% |
|---|---|---|---|---|---|
| 8.6% | $728 | $741 | $756 | $771 | $788 |
| 9.1% | $690 | $701 | $713 | $725 | $739 |
| 9.6% | $656 | $666 | $675 | $686 | $697 |
| 10.1% | $627 | $634 | $643 | $652 | $661 |
| 10.6% | $600 | $607 | $614 | $621 | $630 |
Upcoming earnings date and setup when available.
Das Rating, das die veröffentlichte Research-Ausgabe des jeweiligen Monats trug. Ein Rating vergleicht den Kurs zum Analysezeitpunkt mit dem Fair Value; es ist kein Nachweis, ob die Einschätzung zutraf.
| Jahr | Jan | Feb | Mär | Apr | Mai | Jun | Jul | Aug | Sep | Okt | Nov | Dez |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |